financial post
Junshi Biosciences Announces FDA’s Approval of IND Application for Phase 2/3 Clinical Study of JS207 for the Neoadjuvant Treatment of NSCLC Patients
Financial Post • 2 MONTHS AGO
ECB Governing Council Member Says Price Effects of US Tariffs Still Unclear
Financial Post • 2 MONTHS AGO
South Bow Announces Timing of Third-quarter 2025 Results and Conference Call and Webcast
Financial Post • 2 MONTHS AGO
Apollo Files NI 43-101 Technical Report for the Calico Silver Project Updated Mineral Resource Estimate
Financial Post • 2 MONTHS AGO
Strike by B.C.’s professionals could delay national-interest mine project: union
Financial Post • 2 MONTHS AGO
Louisiana judge orders review of Gulf Coast liquefied natural gas facility’s climate change impacts
Financial Post • 2 MONTHS AGO
Cartier Silver Announces Upsize of Previously Announced Brokered Private Placement to $2.0M Led by Centurion One Capital
Financial Post • 2 MONTHS AGO